In contrast, no significant levels of PADI4 were detected in various benign tumors including leiomyomas of the stomach, uterine myomas, endometrial hyperplasias, cervical polyps, teratomas, hydatidiform moles, trophoblastic cell hyperplasias, hyroid adenomas, hemangiomas, lymph hyperplasias, schwannomas, neurofibromas, lipomas, and cavernous hemangiomas of the liver (IRS: 0–1). Here, PADI4 is linked to lipoma.